Tag: Cancer: Rectal
Steep Increase Seen in Incidence of CRC From Age 49 to 50 Years
Increases seen across the U.S., in men and women, in whites and blacks, for colon and rectal cancers
Social Support Linked to Mortality in Older Women With CRC
Low and moderate perceived social support linked to higher mortality in postmenopausal women with CRC
QoL Extended With Atezolizumab + Bevacizumab in Liver Cancer
And, triplet and doublet drug regimens delay decline in quality of life in BRAF V600E metastatic CRC
Disparities Seen in Outcomes for Young Adults With CRC
Risk for death higher for those from lowest versus highest income and education areas
Colorectal Cancer Risk Still Up in Patients With Ulcerative Colitis
Even after adjustment for tumor stage, patients with ulcerative colitis have higher risk for CRC mortality
Polygenic Risk Score More Strongly Linked to Early-Onset CRC
Strongest association seen for participants without a first-degree family history of colorectal cancer
Continuing Full Induction Regimen Not Beneficial in Metastatic CRC
Maintenance therapy shows benefit versus observation in terms of PFS but not overall survival
Treatment for Younger Adults With CRC Improved Under ACA
Timely receipt of adjuvant chemo more likely in DCE-eligible patients with resected stage IIB to IIIC CRC
CRC Screening Up for Ages 45 to 49 After ACS Guideline Update
Increase in screening rates in quarters 3, 4 of 2018 versus quarter 1; no change for people in their 50s
Four Studies Look at Global Burden of Digestive Diseases
Global burdens of colorectal, pancreatic, stomach cancers and inflammatory bowel disease examined
